Brief: Spanish Regulator Grants Enlivex Authorization To Expand Its Sepsis Phase II Into Spain
04/11/2021 13:11
Nov 4 (Reuters) - Enlivex Therapeutics Ltd ENLV.TA :
* SPANISH REGULATOR GRANTS ENLIVEX AUTHORIZATION TO EXPAND
ITS
SEPSIS PHASE II INTO SPAIN
Source text for Eikon: ID:nGNX14mCLC
Further company coverage: ENLV.TA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Enlivex
See all newsBrief: Enlivex Ltd Registers Up To 23,333,333 Ordinary Shares For Resale By Selling Shareholder
Brief: Enlivex Announces Second Regulatory Approval For Phase 2B Trial Of Allocetra In Age-Related Primary Moderate-To-Severe Knee Osteoarthritis
Brief: Enlivex Therapeutics Files For Offering Of Up To $299.6 Mln Of Ordinary Shares
Brief: Enlivex Announces Positive 6-Month Topline Data For Patients with Knee Osteoarthritis
Brief: Enlivex Files Patent for Allocetra Use in Osteoarthritis Treatment